Regulatory agencies still need to review Pfizer's vaccine on safety: Professor

Joshua Sharfstein from Johns Hopkins Bloomberg School of Public Health says Pfizer's coronavirus vaccine still needs to go through regulatory review for safety, and in the meantime, the public should continue practicing good hygience and social distancing.
Tue, Nov 10 20203:12 AM EST